Journal of Clinical Pediatrics ›› 2024, Vol. 42 ›› Issue (5): 439-444.doi: 10.12372/jcp.2024.23e0242
• Original Article • Previous Articles Next Articles
ZHOU Yiping, DOU Jiaying, CUI Yun, SHI Jingyi, SUN Ting, ZHANG Yucai(
)
Received:2023-03-28
Published:2024-05-15
Online:2024-05-10
ZHOU Yiping, DOU Jiaying, CUI Yun, SHI Jingyi, SUN Ting, ZHANG Yucai. Clinical analysis of the first refractory status epilepticus in pediatric intensive care unit[J].Journal of Clinical Pediatrics, 2024, 42(5): 439-444.
"
| 项 目 | 总人数(n=80) | 死亡组(n=19) | 存活组(n=61) | 统计量 | P |
|---|---|---|---|---|---|
| 性别(男/女) | 39/41 | 8/11 | 31/30 | χ2=0.44 | 0.507 |
| 年龄[M(P25~P75)]/月 | 38(12~80.75) | 48(19~97) | 30(10.50~78.50) | Z=1.01 | 0.311 |
| BMI[M(P25~P75)]/kg·m-2 | 17.20(14.70~19.30) | 16.30(13.20~20.10) | 17.22(15.30~19.20) | Z=0.49 | 0.627 |
| GCS评分[M(P25~P75)] | 7.50(6~11) | 4(3~7) | 8(6~11) | Z=4.27 | <0.001 |
| 临床诊断[n(%)] | |||||
| 重症脑炎 | 50(62.50) | 13(68.42) | 37(60.66) | χ2=0.37 | 0.542 |
| 免疫性脑炎 | 4(5.00) | 0 | 4(6.56) | 0.568 | |
| 癫痫综合征 | 9(11.25) | 0 | 9(14.75) | 0.106 | |
| 颅内出血或占位 | 7(8.75) | 3(15.79) | 4(6.56) | 0.348 | |
| 遗传代谢性脑病 | 4(5.00) | 1(5.26) | 3(4.92) | 1.000 | |
| 脓毒症脑病 | 3(3.75) | 0 | 3(4.92) | 1.000 | |
| 化脓性脑膜炎 | 3(3.75) | 2(10.53) | 1(1.64) | 0.139 | |
| 超难治性SE[n(%)] | 12(15.00) | 2(10.53) | 10(16.39) | 0.721 | |
| <48 h使用丙泊酚[n(%)] | 4(5.00) | 1(5.26) | 3(4.92) | χ2=0.30 | 1.000 |
| ≥48 h使用丙泊酚[n(%)] | 8(10.00) | 1(5.26) | 7(11.48) | 0.672 | |
| 机械通气[n(%)] | 53(66.25) | 18(94.74) | 35(57.38) | Z=9.04 | 0.003 |
| 机械通气时间[M(P25~P75)]/h | 96(54~239) | 111.50 (27.50~265.80) | 96(60~234) | Z=0.18 | 0.858 |
| 惊厥持续时间[M(P25~P75)]/h | 19(2~46) | 3(2~40) | 21(2~56.50) | Z=1.49 | 0.136 |
| 影像学阳性/阴性 | 61/16 | 17/0 | 44/16 | 0.016 | |
| 住PICU日数[M(P25~P75)]/d | 8.50(5~17.80) | 5(3~11) | 10(6~19.50) | Z=2.58 | 0.010 |
"
| 项 目 | 结果(n=80) | 死亡组(n=19) | 存活组(n=61) |
|---|---|---|---|
| 重症脑炎病原学[n(%)] | (n=50) | (n=13) | (n=37) |
| 肠道病毒 | 4 (8.00) | 1 (7.69) | 3 (8.11) |
| 流感病毒 | 5 (10.00) | 2 (15.38) | 3 (8.11) |
| 单纯疱疹病毒 | 3 (6.00) | 0 | 3 (8.11) |
| 支原体 | 1 (2.00) | 0 | 1 (2.70) |
| 隐球菌 | 1 (2.00) | 1 (7.69) | 0 |
| 病原不明 | 36 (72.00) | 9 (69.23) | 27 (72.97) |
| MRI诊断[n(%)] | (n=77) | (n=16) | (n=61) |
| 颞叶/海马 | 12 (15.58) | 0 | 12 (19.67) |
| 基底节/丘脑 | 12 (15.58) | 0 | 12 (19.67) |
| 顶枕叶 | 5 (6.49) | 0 | 5 (8.20) |
| 双侧大脑皮质/广泛脑水肿 | 10 (12.99) | 9 (56.25) | 1 (1.64) |
| 小脑半球 | 2 (2.60) | 0 | 2 (3.28) |
| 脑室后角/脑室扩大 | 4 (5.19) | 0 | 4 (6.56) |
| 扣带回 | 1 (1.30) | 0 | 1 (1.64) |
| 颅内多发异常信号 | 5 (6.49) | 2 (12.50) | 3 (4.92) |
| 脑膜脑炎改变 | 4 (5.19) | 3 (18.75) | 1 (1.64) |
| 颅内占位和/或出血 | 6 (7.79) | 2 (12.50) | 4 (6.56) |
| 阴性 | 16 (20.78) | 0 | 16 (26.23) |
| 脑电图[n(%)] | (n=80) | (n=19) | (n=61) |
| 弥漫慢波 | 45 (56.25) | 14 (73.68) | 31 (50.82) |
| 广泛性周期性痫样放电 | 29 (36.25) | 3 (15.79) | 26 (42.62) |
| 高峰失律 | 3 (3.75) | 0 | 3 (4.92) |
| 爆发抑制 | 3 (3.75) | 2 (10.53) | 1 (1.64) |
| 抗癫痫药物[n(%)] | (n=80) | (n=19) | (n=61) |
| 3种 | 40 (50.00) | 13 (68.42) | 27 (44.26) |
| 4~5种 | 30 (37.50) | 6 (31.58) | 24 (39.34) |
| >5种 | 10 (12.50) | 0 | 10 (16.39) |
| 超难治性SE | (n=12) | (n=2) | (n=10) |
| 48 h内使用丙泊酚[n(%)] | 4 (33.33) | 1 (50.00) | 3 (30.00) |
| ≥48 h使用丙泊酚[n(%)] | 8 (66.67) | 1 (50.00) | 7 (70.00) |
| 丙泊酚使用时间[M(P25~P75)]/h | 23 (20.5~445.75) | ||
| 爱可松[n(%)] | 8 (10%) | 0 | 8 (25.81) |
| 爱可松使用时间[M(P25~P75)]/h | 50.50 (14.75~558.75) | ||
| 免疫调节药物[n(%)] | |||
| 注射用甲基泼尼松龙琥珀酸钠 | 56 (70.00) | 13 (68.42) | 43 (70.49) |
| 静注人免疫球蛋白 | 56 (70.00) | 13 (68.42) | 43 (70.49) |
| 血浆置换 | 14 (17.50) | 0 | 14 (22.95) |
| 利妥昔单抗注射液 | 1 (1.25) | 0 | 1 (1.64) |
| [1] |
Trinka E, Cock H, Hesdorffer D, et al. A definition and classification of status epilepticus--Report of the ILAE Task Force on Classification of Status Epilepticus[J]. Epilepsia, 2015, 56(10): 1515-1523.
doi: 10.1111/epi.13121 pmid: 26336950 |
| [2] |
Kirmani BF, Au K, Ayari L, et al. Super-refractory status epilepticus: prognosis and recent advances in management[J]. Aging Dis, 2021, 12(4): 1097-1119.
doi: 10.14336/AD.2021.0302 |
| [3] | Marawar R, Basha M, Mahulikar A, et al. Updates in refractory status epilepticus[J]. Crit Care Res Pract, 2018, 5(8): 9768949. |
| [4] |
Johnson EL, Kaplan PW. Status epilepticus: definition, classification, pathophysiology, and epidemiology[J]. Semin Neurol, 2020, 40(6): 647-651.
doi: 10.1055/s-0040-1718722 pmid: 33176371 |
| [5] |
Zimmern V, Korff C. Status epilepticus in children[J]. J Clin Neurophysiol, 2020, 37(5): 429-433.
doi: 10.1097/WNP.0000000000000657 pmid: 32890065 |
| [6] |
Chin RFM. The outcomes of childhood convulsive status epilepticus[J]. Epilepsy Behav, 2019, 101(Pt B): 106286.
doi: 10.1016/j.yebeh.2019.04.039 |
| [7] |
Pujar SS, Martinos MM, Cortina-Borja M, et al. Long-term prognosis after childhood convulsive status epilepticus: a prospective cohort study[J]. Lancet Child Adolesc Health, 2018, 2(2): 103-111.
doi: S2352-4642(17)30174-8 pmid: 30169233 |
| [8] |
Martinos MM, Pujar S, Gillberg C, et al. Long-term behavioural outcomes after paediatric convulsive status epilepticus: a population-based cohort study[J]. Dev Med Child Neurol, 2018, 60(4): 409-416.
doi: 10.1111/dmcn.13636 pmid: 29226310 |
| [9] |
Vasquez A, Farias-Moeller R, Tatum W. Pediatric refractory and super-refractory status epilepticus[J]. Seizure, 2019, 68: 62-71.
doi: S1059-1311(18)30025-6 pmid: 29941225 |
| [10] |
Kantanen AM, Kälviäinen R, Parviainen I, et al. Predictors of hospital and one-year mortality in intensive care patients with refractory status epilepticus: a population-based study[J]. Crit Care, 2017, 21(1): 71.
doi: 10.1186/s13054-017-1661-x |
| [11] | Ascoli M, Ferlazzo E, Gasparini S, et al. Epidemiology and outcomes of status epilepticus[J]. Int J Gen Med, 2021, 28(14): 2965-2973. |
| [12] |
Vossler DG, Bainbridge JL, Boggs JG, et al. Treatment of refractory convulsive status epilepticus: a comprehensive review by the American Epilepsy Society Treatments Committee[J]. Epilepsy Curr, 2020, 20(5): 245-264.
doi: 10.1177/1535759720928269 |
| [13] |
Neligan A, Noyce AJ, Gosavi TD, et al. Change in mortality of generalized convulsive status epilepticus in high-income countries over time: a systematic review and meta-analysis[J]. JAMA Neurol, 2019, 76(8): 897-905.
doi: 10.1001/jamaneurol.2019.1268 |
| [14] | Lv RJ, Wang Q, Cui T, et al. Status epilepticus-related etiology, incidence and mortality: A meta-analysis[J]. Epilepsy Res, 2017, 10(136): 12-17. |
| [15] |
Lattanzi S, Leitinger M, Rocchi C, et al. Unraveling the enigma of new-onset refractory status epilepticus: a systematic review of aetiologies[J]. Eur J Neurol, 2022, 29(2): 626-647.
doi: 10.1111/ene.v29.2 |
| [16] |
Wickstrom R, Taraschenko O, Dilena R, et al. International consensus recommendations for management of new onset refractory status epilepticus including febrile infection‐related epilepsy syndrome: statements and supporting evidence[J]. Epilepsia, 2022, 63(11): 2840-2864.
doi: 10.1111/epi.v63.11 |
| [17] |
Brugman J, Solomons RS, Lombard C, et al. Risk-stratification of children presenting to ambulatory paediatrics with first-onset seizures: should we order an urgent CT brain?[J]. J Trop Pediatr, 2020, 66(3): 299-314.
doi: 10.1093/tropej/fmz071 |
| [18] | Al-Shami R, Khair AM, Elseid M, et al. Neuro-imaging evaluation after the first afebrile seizure in children: a retrospective observational study[J]. Seizure, 2016, 12(43): 26-31. |
| [19] |
Glauser T, Shinnar S, Gloss D, et al. Evidence-based guideline: treatment of convulsive status epilepticus in children and adults: report of the Guideline Committee of the American Epilepsy Society[J]. Epilepsy Curr, 2016, 16(1): 48-61.
doi: 10.5698/1535-7597-16.1.48 pmid: 26900382 |
| [20] |
Sidharth, Sharma S, Jain P, et al. Status Epilepticus in Pediatric patients Severity Score (STEPSS): a clinical score to predict the outcome of status epilepticus in children- a prospective cohort study[J]. Seizure, 2019, 71: 328-332.
doi: S1059-1311(19)30426-1 pmid: 31536850 |
| [21] |
Kapoor D, Sidharth, Garg D, et al. Utility of the END-IT score to predict the outcome of childhood status epilepticus: a retrospective cohort study[J]. Ann Indian Acad Neurol, 2021, 24(3): 390-395.
doi: 10.4103/aian.AIAN_1319_20 |
| [22] | Vasquez A, Farias-Moeller R, Sánchez-Fernández I, et al. Super-refractory status epilepticus in children: a retrospective cohort study[J]. Pediatr Crit Care Med, 2021, 22(12): e613-e625. |
| [23] | Rebchuk AD, O'Neill ZR, Szefer EK, et al. Health utility weighting of the modified rankin scale: a systematic review and meta-analysis[J]. JAMA Netw Open, 2020, 3(4): e203767. |
| [1] | GU Xinjia, ZHENG Zhihui, MEI Lingli, ZHENG Jinxin, LIU Taixiang, ZHU Jihua. Burden of urinary system diseases in children and adolescents in China, 1990-2023 [J]. Journal of Clinical Pediatrics, 2026, 44(6): 546-555. |
| [2] | CHEN Zhe, HONG Siqi. Clinical application of tocilizumab in febrile infection-related epilepsy syndrome [J]. Journal of Clinical Pediatrics, 2026, 44(3): 264-269. |
| [3] | LI Yun, GAO Hongbo, DI Yuqing, LI Longmin, LIU Haichun, ZHANG Xiaoyong, SHAO Yujun. Clinical characteristics and prognosis of metastatic pheochromocytoma and paraganglioma in children and adolescents [J]. Journal of Clinical Pediatrics, 2026, 44(2): 118-123. |
| [4] | LIU Yun, PAN Jingjing, SHEN Jinxin, ZOU Yunsu, CHENG Rui, FENG Yun, YANG Yang. Therapeutic efficacy of surfactant supplementation after pulmonary hemorrhage in improving clinical outcomes of preterm infants with gestational age <34 weeks [J]. Journal of Clinical Pediatrics, 2025, 43(9): 652-660. |
| [5] | XU Shiyi, DU Min, BAI Lixia, LIU Aihong. Research progress on severe pertussis in infants and young children [J]. Journal of Clinical Pediatrics, 2025, 43(5): 383-388. |
| [6] | ZHAI Yu, DUAN Suxia, JIA Fanping, JIA Yongping, ZHANG Jingjing, GUO Yinghui. Analysis of epidemiological characteristics of respiratory tract Boca virus infection in children: a single-center retrospective study [J]. Journal of Clinical Pediatrics, 2025, 43(3): 184-190. |
| [7] | HUANG Liufang, WU Bo, WANG Ying. An analysis of predictive markers for surgical treatment of ulcerative colitis in children [J]. Journal of Clinical Pediatrics, 2025, 43(2): 120-127. |
| [8] | ZHANG Shuo, ZHAO Xuemin, SHEN Xiuhua. The effect of vegetarian diet on children and adolescents [J]. Journal of Clinical Pediatrics, 2025, 43(2): 157-162. |
| [9] | YANG Jun, CHEN Jianyong. Hearing impairment in infants and young children: from precision diagnosis to personalized intervention and systematic follow-up [J]. Journal of Clinical Pediatrics, 2025, 43(12): 890-896. |
| [10] | WANG Wei, WANG Lu, SHEN Jiali, MA Xiaobao, HE Kuan, SONG Jiayue, CHEN Jianyong, YANG Jun, JIN Yulian. Air-conduction tone burst auditory brainstem response thresholds in infants and young children with otitis media with effusion [J]. Journal of Clinical Pediatrics, 2025, 43(12): 902-907. |
| [11] | DIAO Cong, SHEN Yiwen, WANG Qiang, ZHAO Yu, MENG Zhaoli. Multidimensional assessment of differences in auditory processing ability between slight-mild hearing loss and normal-hearing school-age children [J]. Journal of Clinical Pediatrics, 2025, 43(12): 922-927. |
| [12] | MA Xiaobao, SHEN Jiali, WANG Wei, WANG Lu, LOU Gaozhong, ZHAO Zhehong, JIN Yulian, YANG Jun, CHEN Jianyong, QIN Huan. Establishment of an age-latency function model for wave Ⅴ of bone-conduction click-evoked auditory brainstem responses in normal-hearing infants and young children [J]. Journal of Clinical Pediatrics, 2025, 43(12): 933-939. |
| [13] | CHANG Guoying, YANG Fan, YIN Lei, YUAN Jiajun, WANG Xiumin. From "Passive Continuation" to "Active Transition": Clinical practice and reflection on continuation therapy for pediatric and adolescent rare diseases [J]. Journal of Clinical Pediatrics, 2025, 43(10): 723-726. |
| [14] | FENG Lian, HU Junlong, HUANG Hui, LI Xiaozhong, LI Yanhong. Predictive value of urinary CXCL10 for mortality risk of critically ill children in PICU [J]. Journal of Clinical Pediatrics, 2024, 42(7): 631-636. |
| [15] | MAO Meng, SHAO Jie, CHEN Jinjin, SHEN Lixiao. Interpretation of Catch-up growth in infants and young children with faltering growth: expert opinion to guide general clinicians [J]. Journal of Clinical Pediatrics, 2024, 42(5): 390-398. |
|
||